Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$36.38

0.72 (2.02%)

06:34
10/06/16
10/06
06:34
10/06/16
06:34

Ionis Pharmaceuticals upgraded to Outperform from Market Perform at BMO Capital

  • 07

    Oct

IONS Ionis Pharmaceuticals
$36.38

0.72 (2.02%)

09/26/16
PIPR
09/26/16
NO CHANGE
Target $46
PIPR
Overweight
Ionis nusinersen program advancing faster than expected, says Piper Jaffray
After Biogen (BIIB) and Ionis (IONS) announced that Biogen has completed the rolling submission of a New Drug Application to the U.S. FDA for the approval of nusinersen, an investigational treatment for spinal muscular atrophy, Piper Jaffray analyst Joshua Schimmer said that the nusinersen program is advancing faster than many have expected. Nusinersen may launch before AveXis (AVXS) starts its next Phase 3 trial, added Schimmer, who believes nusinersen will emerge as a multi-billion dollar product. The analyst keeps an Overweight rating and $46 price target on Ionis shares.
09/28/16
JEFF
09/28/16
NO CHANGE
Target $50
JEFF
Buy
Jefferies parent survey shows interest in AveXis pivotal trial
Jefferies analyst Biren Amin conducted a survey of parents of spinal muscular atrophy patients amid investor questions surrounding AveXis' (AVXS) ability to enroll a pivotal trial with AVXS-101 given the open access program with nusinersen, the investigational drug being developed by Ionis Pharmaceuticals (IONS) and Biogen (BIIB). Parents value the option of nusinersen treatment but are also willing to enroll in clinical trials of AVXS-101, Amin tells investors in a research note, citing his survey of seven parents. A single arm trial of AVXS-101 was the most preferred clinical trial design for the upcoming Phase 3 of AVXS-101, he added. The analyst believes his parent responses suggest excitement over nusinersen but also a willingness to enroll into the AVXS-101 trials, especially if it is a single-arm trial. Parents were also attracted to AVXS-101 intravenous delivery, which could be a "meaningful advantage," Amin contends. The analyst keeps a Buy rating on AveXis with a $50 price target. The stock closed yesterday up 88c to $41.00. Amin caused a rally in AveXis shares on September 19 when writing about finding a video online of a spinal muscular atrophy baby walking that he believed to be a patient in the company's trial of AVXS-101.
09/28/16
JANY
09/28/16
INITIATION
Target $47
JANY
Buy
Ionis Pharmaceuticals initiated with a Buy at Janney Capital
Janney Capital analyst Roy Buchanan initiated Ionis Pharmaceuticals with a Buy and a $47 fair value estimate. Buchanan believes the late stage pipeline, including wholly-owned volanesorsen, and the base technology can add meaningful value to Ionis. 1H 2017 is particularly rich with 3 phase 3 readouts, with potential for another early, interim look at SMA.
10/04/16
RBCM
10/04/16
NO CHANGE
Target $375
RBCM
Outperform
Biogen could rise $20 or more per share on SMA success, says RBC Capital
RBC Capital analyst Michael Yee expects the first presentation of data from Biogen's (BIIB) Phase III ENDEAR trial studying nusinersen, an investigational treatment for spinal muscular atrophy, or SMA, this week, potentially during the late breaker session at the WMS Congress on October 8. Biogen and partner Ionis Pharmaceuticals (IONS) already announced in August that the study in Type I infants hit the interim analysis and stopped early for positive data. The much larger opportunity in older children has data expected to read out in Spring 2017, noted Yee, who thinks Biogen can have upside from $10 to over $20 per share based on its SMA opportunity. Yee keeps an Outperform rating and $375 price target on Biogen shares.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$285.30

-5.86 (-2.01%)

15:02
12/08/16
12/08
15:02
12/08/16
15:02
Periodicals
Biogen move higher attributed to data leak from conference »

TheStreet's Adam…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

LNKD

LinkedIn

, MSFT

Microsoft

$61.37

1.42 (2.37%)

14:58
12/08/16
12/08
14:58
12/08/16
14:58
Hot Stocks
NYSE informs SEC of plans to delist LinkedIn stock after Microsoft deal closing »

In a regulatory filing,…

LNKD

LinkedIn

MSFT

Microsoft

$61.37

1.42 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVTB

PrivateBancorp

$52.39

0.25 (0.48%)

, CM

CIBC

$84.66

0.96 (1.15%)

14:55
12/08/16
12/08
14:55
12/08/16
14:55
Hot Stocks
PrivateBancorp at highs as report claims third party approach »

PrivateBancorp (PVTB),…

PVTB

PrivateBancorp

$52.39

0.25 (0.48%)

CM

CIBC

$84.66

0.96 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AVGO

Broadcom

$168.55

3.79 (2.30%)

14:49
12/08/16
12/08
14:49
12/08/16
14:49
Options
Broadcom options imply 6.8% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

SPWR

SunPower

$7.95

0.99 (14.22%)

14:45
12/08/16
12/08
14:45
12/08/16
14:45
Options
SunPower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNSR

Finisar

$32.24

0.51 (1.61%)

14:43
12/08/16
12/08
14:43
12/08/16
14:43
Technical Analysis
Finisar technical comments ahead of earnings news, potential bearish pattern »

The key technical feature…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

MBLY

Mobileye

$35.64

-1.735 (-4.64%)

14:40
12/08/16
12/08
14:40
12/08/16
14:40
Recommendations
Mobileye analyst commentary  »

Mobileye comments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 10

    Jan

MGNX

MacroGenics

$26.47

-1.77 (-6.27%)

14:40
12/08/16
12/08
14:40
12/08/16
14:40
Conference/Events
MacroGenics to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

14:40
12/08/16
12/08
14:40
12/08/16
14:40
General news
FOMC Forecast revisions »

FOMC Forecast revisions…

AZO

AutoZone

$811.19

1.315 (0.16%)

, ORLY

O'Reilly Automotive

$285.20

7.52 (2.71%)

14:39
12/08/16
12/08
14:39
12/08/16
14:39
Hot Stocks
Icahn negative on automotive replacement retailers »

Carl Icahn, while…

AZO

AutoZone

$811.19

1.315 (0.16%)

ORLY

O'Reilly Automotive

$285.20

7.52 (2.71%)

AMZN

Amazon.com

$770.42

5.7 (0.75%)

AAP

Advance Auto Parts

$177.03

0.25 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ESRX

Express Scripts

$75.85

-0.88 (-1.15%)

, VRX

Valeant

$15.54

0.455 (3.02%)

14:38
12/08/16
12/08
14:38
12/08/16
14:38
Hot Stocks
Express Scripts denies being anything 'like Philidor' »

Contacted by The Fly to…

ESRX

Express Scripts

$75.85

-0.88 (-1.15%)

VRX

Valeant

$15.54

0.455 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

  • 16

    Feb

DAL

Delta Air Lines

$51.69

0.59 (1.15%)

14:36
12/08/16
12/08
14:36
12/08/16
14:36
Conference/Events
Delta Air Lines to host investor meeting »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

MTN

Vail Resorts

$161.72

-1.01 (-0.62%)

14:36
12/08/16
12/08
14:36
12/08/16
14:36
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AVGO

Broadcom

$168.55

3.79 (2.30%)

, COO

Cooper Companies

$168.47

0.08 (0.05%)

14:36
12/08/16
12/08
14:36
12/08/16
14:36
Earnings
Notable companies reporting after market close »

Notable companies…

AVGO

Broadcom

$168.55

3.79 (2.30%)

COO

Cooper Companies

$168.47

0.08 (0.05%)

FNSR

Finisar

$32.24

0.51 (1.61%)

RH

Restoration Hardware

$38.65

0.7137 (1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

IWM

iShares Trust Russell 2000 Index Fund

$137.92

2.015 (1.48%)

14:30
12/08/16
12/08
14:30
12/08/16
14:30
Options
Big option play opened in the Small Cap Fund as shares reach new highs »

Big option play opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$7.52

-0.065 (-0.86%)

14:30
12/08/16
12/08
14:30
12/08/16
14:30
Hot Stocks
Icahn says does not own shares of Chesapeake »

Carl Icahn is speaking on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLO

Valero

$68.72

1.18 (1.75%)

, WNR

Western Refining

$39.18

-0.32 (-0.81%)

14:29
12/08/16
12/08
14:29
12/08/16
14:29
Hot Stocks
Icahn says refining stocks sold off because of EPA »

Carl Icahn is speaking on…

VLO

Valero

$68.72

1.18 (1.75%)

WNR

Western Refining

$39.18

-0.32 (-0.81%)

TSO

Tesoro

$90.89

-1.11 (-1.21%)

MPC

Marathon Petroleum

$50.14

0.485 (0.98%)

PSX

Phillips 66

$87.91

0.9 (1.03%)

DK

Delek US

$24.13

0.75 (3.21%)

HFC

HollyFrontier

$33.95

0.93 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:27
12/08/16
12/08
14:27
12/08/16
14:27
Hot Stocks
Icahn says involved with board, news will be out in next week »

Carl Icahn, while…

FB

Facebook

$117.95

0.64 (0.55%)

, TWTR

Twitter

$19.39

-0.0942 (-0.48%)

14:27
12/08/16
12/08
14:27
12/08/16
14:27
Periodicals
Snapchat hits $300M in 2016 sales, sets $1B goal for 2017, The Information says »

Snapchat parent Snap set…

FB

Facebook

$117.95

0.64 (0.55%)

TWTR

Twitter

$19.39

-0.0942 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$62.49

-0.19 (-0.30%)

, MGM

MGM Resorts

$30.52

0.57 (1.90%)

14:26
12/08/16
12/08
14:26
12/08/16
14:26
Periodicals
Macau government to slash ATM withdrawl limit, SCMP reports »

China's government…

LVS

Las Vegas Sands

$62.49

-0.19 (-0.30%)

MGM

MGM Resorts

$30.52

0.57 (1.90%)

WYNN

Wynn Resorts

$101.99

-0.19 (-0.19%)

MPEL

Melco Crown

$19.55

0.13 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$17.32

0.77 (4.65%)

14:25
12/08/16
12/08
14:25
12/08/16
14:25
Options
KB Home call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

LVS

Las Vegas Sands

$62.50

-0.18 (-0.29%)

, MGM

MGM Resorts

$30.55

0.595 (1.99%)

14:21
12/08/16
12/08
14:21
12/08/16
14:21
Periodicals
Breaking Periodicals news story on Las Vegas Sands, MGM Resorts, Wynn Resorts, Melco Crown »

Chinese government to…

LVS

Las Vegas Sands

$62.50

-0.18 (-0.29%)

MGM

MGM Resorts

$30.55

0.595 (1.99%)

WYNN

Wynn Resorts

$101.99

-0.19 (-0.19%)

MPEL

Melco Crown

$19.55

0.13 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$125.39

0.82 (0.66%)

14:19
12/08/16
12/08
14:19
12/08/16
14:19
Periodicals
California weighing tax for online video streaming, Armstrong Economics says »

Officials from Pasadena…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$101.99

-0.19 (-0.19%)

, LVS

Las Vegas Sands

$62.59

-0.09 (-0.14%)

14:19
12/08/16
12/08
14:19
12/08/16
14:19
Hot Stocks
Wynn Resorts, Las Vegas Sands fall sharply »

Several casino stocks,…

WYNN

Wynn Resorts

$101.99

-0.19 (-0.19%)

LVS

Las Vegas Sands

$62.59

-0.09 (-0.14%)

MGM

MGM Resorts

$30.55

0.595 (1.99%)

MPEL

Melco Crown

$19.55

0.13 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAI

Reynolds American

$54.90

-0.04 (-0.07%)

, PM

Philip Morris

$89.72

-0.155 (-0.17%)

14:18
12/08/16
12/08
14:18
12/08/16
14:18
Hot Stocks
U.S. Surgeon General: E-cigarettes pose 'significant' risk to young people »

U.S. Surgeon General…

RAI

Reynolds American

$54.90

-0.04 (-0.07%)

PM

Philip Morris

$89.72

-0.155 (-0.17%)

MO

Altria Group

$65.42

0.01 (0.02%)

VGR

Vector Group

$21.96

0.28 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.